RSV Epidemiology and Molecular Diversity study version 2.0
Research type
Research Study
Full title
RSV Epidemiology and Molecular Diversity - a pilot study in NW London during the 2021/2022 RSV season
IRAS ID
298527
Contact name
Paul Randell
Contact email
Sponsor organisation
Imperial College
Duration of Study in the UK
0 years, 6 months, 0 days
Research summary
Respiratory Syncytial Virus (RSV) is a leading cause of acute respiratory tract infections in infants and causes significant numbers of hospital admissions and deaths globally every year. Prevention of RSV is a major global priority but despite more than 50 years of research there is no safe and effective vaccine. The successful introduction of newer therapeutics or vaccines requires an understanding of the epidemiology and viral diversity that may impact the efficacy of these agents. Despite all that is known about RSV there is still a paucity in the understanding of RSV epidemiology.
This pilot study aims to describe the epidemiology of patients testing positive in NW London during the 2021/2022 RSV season. While the burden of disease is primarily in the paediatric patient group, the data from adults and children with be investigated to gain greater understanding of the local RSV transmission dynamics and molecular diversity of the virus.
REC name
North West - Haydock Research Ethics Committee
REC reference
22/NW/0165
Date of REC Opinion
16 Jun 2022
REC opinion
Further Information Favourable Opinion